← FRIAS Early Career Fellowship 2026 MODERATE Neuropharm/CCT
Programme Research
FRIAS Early Career Fellowship 2026 ·
Programme Site
HIGH confidence Researched 2026-08-04 20:56 · profile: researcher
The FRIAS Early Career Fellowship funds postdoctoral researchers to spend 4-10 months at the University of Freiburg, providing time, resources, and access to an interdisciplinary academic community to pursue a self-defined research project. It exists to foster cross-disciplinary collaboration and support early-career scholars in developing their independent research agenda.
- Completed doctoral degree (PhD) and maximum of 8 years of post-doctoral experience. - At least 4 peer-reviewed publications since 1 January 2021. - At least 6 months of research/study experience in a country different from the country of first academic degree. - Challenging and innovative research project of top academic quality. - Strictly merit-based selection, expected success rate ~10%. - Full-time presence at FRIAS is mandatory during the fellowship. - Applications from any discipline that can be supported at the University of Freiburg; alignment with university research strengths is encouraged. - Required materials: online form (abstract, layman's abstract, motivation statement, ethical issue table), project proposal (max 3000 words, 4 graphs), CV (tabular, mandatory template), publication list (max 8, 4 peer-reviewed after 2021), PhD diploma, letter of support (only for experimental scientists), experiment sketch/timetable (only for experimental scientists).
The page does not list past winners. However, typical FRIAS Early Career Fellows are postdoctoral researchers with a strong publication record, an innovative and interdisciplinary project, and a clear plan for collaboration with Freiburg faculty. They come from various disciplines and countries, often with prior international mobility.
A postdoctoral researcher with a completed PhD, 4+ recent peer-reviewed publications, international research experience, and a bold, interdisciplinary project that would benefit from a 4-10 month residency at FRIAS. The ideal candidate demonstrates top academic quality, a clear plan for collaboration with Freiburg researchers, and the ability to communicate their research to a general audience.
Eniola's strongest angle is the CCT model, as it is his most mature and impactful research line with three sole-authored preprints under review, Bayesian-calibrated modeling, and confirmed hypotheses. The CCT project aligns with FRIAS's interdisciplinary focus (neuroscience, pharmacology, computational modeling) and can be framed as a challenging, innovative project that would benefit from collaboration with Freiburg's neuroscience and computational research groups. Eniola should emphasize his international mobility (Nigeria to Germany) and his recent enrollment in a German MSc, which demonstrates commitment to the German academic system, while noting that his PhD is not yet completed—this is a critical eligibility issue.
Eligibility concern: The programme requires a completed doctoral degree. Eniola has a B.Pharm and is enrolled in an M.Sc., but does not hold a PhD. This is a hard eligibility requirement and would disqualify him unless he has a PhD not mentioned in the profile. Also, the requirement of 4 peer-reviewed publications since 2021 may be challenging: his preprints are under review, not yet published. Additionally, the mandatory full-time presence at FRIAS (4-10 months) may conflict with his M.Sc. enrollment at HPI/Potsdam, though it could be scheduled during a break. The application deadline (12 September 2025) is before his M.Sc. starts (Winter 2026/27), so he would need to clarify his availability.
2026-08-04 20:28 · high confidence
2026-08-04 19:53 · high confidence
2026-07-30 08:37 · high confidence